Vir Biotechnology (NASDAQ: VIR)
You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Vir Biotechnology Returns vs. S&P
|1 Year||5 Year||5 Year Annualized||Since IPO|
Vir Biotechnology Company Info
News & Analysis
These growth stocks have substantial tailwinds.
The innovative companies have made great gains in a short period of time.
A COVID-19 partnership with a major drugmaker is producing more fruit than expected.
Joining the S&P SmallCap 600 could boost the company's profile.
The S&P SmallCap 600 index will soon include Vir.
Looking for small healthcare companies with huge revenue opportunities? Try these.
Vir Bio has a COVID blockbuster in Xevudy, and the stock is super-cheap right now.
The immunology specialist says it can help combat omicron.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.